FibroGen (FGEN) – Analyst PT Change
-
BofA Securities Downgrades FibroGen (FGEN) to Underperform, 'unfavorable catalyst pathway'
-
FibroGen (FGEN) PT Lowered to $2 at Goldman Sachs
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to FGEN Stock Lookup